Bellwether trials are widely expected after those expert and dispositive-motion phases, but publicly available court scheduling documents do not yet set specific trial dates, so mid-2026 should be treated as a projection rather than a court-ordered start date
According to the FDA: Its approved to lower blood sugar levels in adults with type 2 diabetes mellitus, in addition to diet and exercise. The significant mechanism in drugs like Ozempic and Wegovy is semaglutide, which mimics the GLP-1 hormone released in the gastrointestinal tract in response to eating. Further, GLP-1 prompts the body to produce more insulin, which reduces blood glucose (sugar). It also sends signals to your brain and stomach that youre full, decreasing the amount you eat
FDA News Release (Note: This link is illustrative of FDA announcements
Weekly dosing is clinically recommended
New York State Medicaid For patients with diabetes on NY Medicaid: Step therapy is required
GHRH-GHSR Synergy Bowers et al